Previous 10 | Next 10 |
2024-02-14 13:13:56 ET More on Uber, Alphabet, etc. Uber Technologies, Inc. (UBER) Virtual Investor Update Call Transcript Here's What Could Make Amazon Even More Profitable Nvidia overtakes Google to become third-largest U.S. company Eminence Capital adds Se...
2024-02-14 00:14:02 ET Summary DexCom reported strong financial growth in the fourth quarter of 2023, with worldwide revenue reaching $1.035 billion. The company is focused on expanding its global presence and advancing its technological capabilities, including the upcoming launch...
2024-02-08 21:00:26 ET DexCom, Inc. (DXCM) Q4 2023 Earnings Conference Call February 8, 2024 4:30 PM ET Company Participants Sean Christensen - Head of Investor Relations Kevin Sayer - Chairman, President, and Chief Executive Officer Jereme Sylvain - Chief Financ...
2024-02-08 19:45:21 ET Image source: The Motley Fool. DexCom (NASDAQ: DXCM) Q4 2023 Earnings Call Feb 08, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: DexCom (DXCM) Q4 2023 Earnings Call Transcript
2024-02-08 16:14:23 ET More on DexCom DexCom: Stelo Stellar Outlook Up 60%, Why I Believe DexCom Is One Of The Best Healthcare Stocks Money Can Buy Seeking Alpha’s Quant Rating on DexCom Read the full article on Seeking Alpha For further detail...
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Revenue grew 27% versus the same quarter of the prior year to $1.03 billion on a reported basis and 26% on ...
2024-02-08 10:00:00 ET Every investor wants to beat the market, but doing so is notoriously difficult. That's why many settle for matching the performance of some prominent index by buying the appropriate exchange-traded funds (ETFs). However, it's possible to crush the market by invest...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
2024-02-07 17:20:17 ET More on DexCom DexCom: Stelo Stellar Outlook Up 60%, Why I Believe DexCom Is One Of The Best Healthcare Stocks Money Can Buy Baird bullish on medtech in 2024, but sees weakness in dental market Dexcom stock rises 4% on preliminary Q4 re...
2024-02-07 14:15:08 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...
News, Short Squeeze, Breakout and More Instantly...
Diabetes management goes hands-free as Dexcom G7 now connects directly to Apple Watch * in the U.S., giving users confidence even when their iPhone isn’t with them † As the first and only CGM system that connects directly to Apple Watch, * Dexcom G7 gives users t...
2024-06-04 11:30:03 ET Bernstein analyst issues OUTPERFORM recommendation for DXCM on June 4, 2024 09:14AM ET. The previous analyst recommendation was Outperform. DXCM was trading at $115.76 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in access to its products for those treating Type 2 diabetes (T2D) with basal insulin injections. The company, which pioneered CGM technolo...